The global multiple myeloma therapeutics market size is estimated to reach USD 30.30 billion by 2030 and is projected to grow at a CAGR of 5.5% from 2024 to 2030. Key factors driving the market expansion include constant introduction of newer and effective therapeutic options and high adoption rates of the same. This space is expected to gain momentum with the addition of novel...